
CRADA Final Report: ErbB2 Targeted Cancer Therapeutics
Author(s) -
Ruth Lupu
Publication year - 2002
Language(s) - Uncategorized
Resource type - Reports
DOI - 10.2172/1157017
Subject(s) - cancer research , erbb , breast cancer , neuregulin , receptor tyrosine kinase , medicine , activator (genetics) , prostate cancer , targeted therapy , ovarian cancer , prostate , oncogene , ovarian carcinomas , oncology , cancer , receptor , ovarian carcinoma , cell cycle